AQUILA

- EUR (-)

- 15 min delayed data - Euronext Paris

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	ALAQU
ISIN:	FR0010340711

AQUILA overview

> News GlobeNewsWire published a news.

Merus N.V. Receives €1.5 Million EUREKA Eurostars Grant with Aquila BioMedical Ltd to Jointly Develop Immunological Assays for Identification of Novel Immunomodulatory Bispecific Antibodies • • GlobeNewsWire • Stocks • More AQUILA news...

UTRECHT, The Netherlands and EDINBURGH, UK, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, announced today that it has been awarded a €1.5 million EUREKA Eurostars grant (“iMOD-ReACT”) with Aquila BioMedical, Ltd. to jointly develop novel immunological assays supporting the selection of potent bispecific antibodies that positively modulate tumor immunity with superior potency and...

Thank you Chart

> News Bloomberg posted a new video.

Aquila Sees Unsolicited Takeover Bids by Household Names: Video • • Bloomberg • Stocks • More AQUILA news...

Oct. 2 (Bloomberg) -- Frank Aquila, a partner at Sullivan & Cromwell LLP, talks with Bloomberg's Lori Rothman about the outlook for mergers and acquisitions....

Thank you Chart

> News Bloomberg posted a new video.

Aquila Sees Rise in Global Mergers & Acquisitions Market: Video • • Bloomberg • Stocks • More AQUILA news...

Nov. 6 (Bloomberg) -- Frank Aquila, a partner at Sullivan & Cromwell LLP, talks with Bloomberg's Lori Rothman about the outlook for mergers and acquisitions....

Thank you Chart

> News Bloomberg posted a new video.

Aquila Expects M&A Activity to Rise in 2011: BLAW • • Bloomberg • Stocks • More AQUILA news...

Jan. 18 (Bloomberg) -- Frank Aquila, partner at Sullivan & Cromwell LLP, talks with Bloomberg Law's Lee Pacchia about the U.S. economy and prospects for ......

Thank you Chart

Load more content